A single-nucleotide polymorphism in the human THADA gene is associated with circulating resistin in the general Japanese population

DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992;15:318–68. McCarthy MI, Zeggini E. Genetics of type 2 diabetes. Curr Diabetes Rep. 2006;6:147–54. Stolerman ES, Florez JC. Genomics of type 2 diabetes mellitus: implications for the clinician. Nat Rev Endocrinol. 2009;5:429–36. Tabara Y, Osawa H, Kawamoto R, et al. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes. 2009;58:493–8. Yamauchi T, Hara K, Maeda S, et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A–C2CD4B. Nat Genet. 2010;42:864–8. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med. 2010;363:2339–50. Steppan C, Lazar M. The current biology of resistin. J Intern Med. 2004;255:439–47. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307–12. Rangwala S, Rich A, Rhoades B, et al. Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes. 2004;53:1937–41. Banerjee R, Rangwala S, Shapiro J, et al. Regulation of fasted blood glucose by resistin. Science. 2004;303:1195–8. Curat CA, Wegner V, Sengenes C, et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia. 2006;49:744–7. Nagaev I, Bokarewa M, Tarkowski A, et al. Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS ONE. 2006;1:e31. Patel L, Buckels A, Kinghorn I, et al. Resistin is expressed in human macrophages and directly regulated by PPARγ activators. Biochem Biophys Res Commun. 2003;300:472–6. Osawa H, Onuma H, Murakami A, et al. Systematic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes. Diabetes. 2002;51:863–6. Osawa H, Yamada K, Onuma H, et al. The G/G genotype of a resistin single-nucleotide polymorphism at −420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet. 2004;75:678–86. Osawa H, Onuma H, Ochi M, et al. Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Biophys Res Commun. 2005;335:596–602. Osawa H, Tabara Y, Kawamoto R, et al. Plasma resistin, associated with single nucleotide polymorphism −420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care. 2007;30:1501–6. Osawa H, Tabara Y, Kawamoto R, et al. PPARγ Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes are synergistically associated with plasma resistin in the Japanese general population. Clin Endocrinol (Oxf). 2009;71:341–5. Onuma H, Tabara Y, Kawamura R, et al. A at single nucleotide polymorphism −358 is required for G at −420 to cofer the highest plasma resistin in the general Japanese population. PLoS One. 2010;5:e9718. Hivert MF, Manning AK, McAteer JB, et al. Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study. Diabetes. 2009;58:750–6. Tokuyama Y, Osawa H, Ishizuka T, et al. Serum resistin level is associated with insulin sensitivity in Japanese type 2 diabetes. Metabolism. 2007;56:693–8. Qatanani M, Szwergold N, Greaves D, et al. Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J Clin Invest. 2009;119:531–9. Drieschner N, Belge G, Rippe V, et al. Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin. Thyroid. 2006;16:1091–6. Zeggini E, Scott LJ, Saxena R, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008;40:638–45. Drieschner N, Kerschling S, Soller JT, et al. A domain of the thyroid adenoma associated gene (THADA) conserved in vertebrates becomes destroyed by chromosomal rearrangements observed in thyroid adenomas. Gene. 2007;403:110–7. Simonis-Bik AM, Nijpels G, van Haeften TW, et al. Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function. Diabetes. 2010;59:293–301. McCarthy MI, Zeggini E. Genome-wide association studies in type 2 diabetes. Curr Diabetes Rep. 2009;9:164–71. Osawa H, Doi Y, Makino H, et al. Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study. Cardiovasc Diabetol. 2009;8:60. Kawamura R, Doi Y, Osawa H, et al. Circulating resistin is increased with decreasing renal function in a general Japanese population: the Hisayama Study. Nephrol Dial Transpl. 2010;25:3236–40. Schwartz DR, Lazar MA. Human resistin: found in translation from mouse to man. Trends Endocrinol Metab. 2011;22:259–65.